Type 2 Diabetes

Severe hypoglycemic episodes are a marker of, rather than causally related to, an increased risk for death among adults with type 2 diabetes, according to data published in Diabetologia.

The risk for type 2 diabetes remains high more than 2 decades after pregnancy for women with gestational diabetes, whereas the risk for type 1 diabetes subsides after 7 years, according to data from a 23-year follow-up study in Finland.

Adults with type 2 diabetes and worsening HF or at CV risk assigned the dual SGLT1/SGLT2 inhibitor sotagliflozin saw reduced risk for CV death and hospitalization or urgent visits for HF compared with placebo.

The growing diabetes epidemic requires urgent actions to reduce disease burden worldwide, including new, team-based approaches and data-driven integrated care, according to an action plan published in The Lancet.

Type 2 diabetes remission with weight loss is possible and most likely for individuals who sustain more weight loss, who are younger and who have had diabetes for a shorter time, according to a speaker.

Data show Black adults with type 2 diabetes and moderate chronic kidney disease were significantly less likely to receive a metformin prescription compared with white counterparts under an old FDA serum creatinine-based metformin label.

Green tea and coffee consumption may reduce the risk for mortality among adults with type 2 diabetes, according to a recent study. It was the top story in endocrinology last week. 

Japanese adults with type 2 diabetes who drank more green tea and coffee were less likely to die of any cause during 5 years of follow-up; the combined effect of the two beverages appeared to be additive, study data show.

Dapagliflozin reduced the worsening of kidney function and the risk of cardiovascular or renal death in patients with chronic kidney disease irrespective of the underlying cause of kidney disease, according to recently presented data.

Analysis of human induced-pluripotential stem cells reveals a complex, multi-dimensional network of signaling defects that could help researchers better understand insulin resistance, according to a speaker.